Chronic granulomatous disease (CGD) is characterized by the failure of phagocytic leukocytes to generate superoxide, needed for the intracellular killing of microorganisms. This is caused by mutations in any one of the four subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In a rare, autosomal recessive form ofCGD, a 67-kD cytosolic component of this enzyme (p67-phox) is missing. We here report on a patient with a mutation in the p67-phox gene that leads to expression of a nonfunctional p67-phox protein. The purified granulocytes of this patient failed to produce superoxide and contained about half of the normal amount ofp67-phox. Analysis of the cDNA and genomic DNA of this patient showed that the patient is a compound heterozygote for a triplet nucleotide deletion in the p67-phox gene, predicting an in-frame deletion oflysine 58 in the p67-phox protein and a larger deletion of 11-13 kb in the other allele. Interestingly, the S8Lys deletion in p67-phox disrupts the interaction with p21-rac1, a ras-related protein involved in the activation of the NADPH oxidase. In contrast to normal neutrophils, in which p47-phox and p67-phox translocate to the plasma membrane upon cell activation, the cells of the patient did not show this translocation, indicating that an interaction between p67-phox and p21-racl is essential for translocation of these cytosolic proteins and activation of the NADPH oxidase. Moreover, this CGD patient represents the first case of a disease caused by a disturbed binding of a ras-related protein to its target protein.
Sumnlary
Chronic granulomatous disease (CGD) is characterized by the failure of phagocytic leukocytes to generate superoxide, needed for the intracellular killing of microorganisms. This is caused by mutations in any one of the four subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In a rare, autosomal recessive form ofCGD, a 67-kD cytosolic component of this enzyme (p67-phox) is missing. We here report on a patient with a mutation in the p67-phox gene that leads to expression of a nonfunctional p67-phox protein. The purified granulocytes of this patient failed to produce superoxide and contained about half of the normal amount ofp67-phox. Analysis of the cDNA and genomic DNA of this patient showed that the patient is a compound heterozygote for a triplet nucleotide deletion in the p67-phox gene, predicting an in-frame deletion oflysine 58 in the p67-phox protein and a larger deletion of 11-13 kb in the other allele. Interestingly, the S8Lys deletion in p67-phox disrupts the interaction with p21-rac1, a ras-related protein involved in the activation of the NADPH oxidase. In contrast to normal neutrophils, in which p47-phox and p67-phox translocate to the plasma membrane upon cell activation, the cells of the patient did not show this translocation, indicating that an interaction between p67-phox and p21-racl is essential for translocation of these cytosolic proteins and activation of the NADPH oxidase. Moreover, this CGD patient represents the first case of a disease caused by a disturbed binding of a ras-related protein to its target protein.
p hagocytic leukocytes use reactive oxygen metabolites to kill ingested microorganisms. The first step in the production of these compounds is the generation of superoxide by the nicotinamide adenine dinucleotide phosphate (NADPH) 1 oxidase enzyme in these cells. This enzyme consists of a flavocytochrome (cytochrome bs_ss), located in the plasma membrane (1), and several cytosolic components that translocate to the plasma membrane upon activation of the oxidase (2, 3) . This activation is initiated by at1Abbreviations used in this paper: CGD, chronic granulomatous disease; FAD, flavin adenine dinucleotide; GST, glutathione-S-transferase; NADPH, nicotinamide adenine dinucleotide phosphate; PAF. platelet-activating factor; SOl), superoxide dismutase; STZ, serum-treated zymosan. tachment of opsonized microorganisms to cell surface receptors and serves to restrict the generation of the reactive oxygen compounds to periods ofphagocytosis. During activation, the 47-and the 67-kD cytosolic oxidase components (called p47-phox and p67-phox, respectively) couple to the flavocytochrome and probably induce a conformational change in this protein that renders its flavin accessible to NADPH (4) . As a result, electrons flow from NADPH via flavin adenine dinucleotide (FAD) and heme to oxygen, thus generating superoxide.
Mutations in either the ix or the 13 subunit of cytochrome bss 8 in p47-phox or in p67-phox lead to a dysfunction of the NADPH oxidase enzyme (5) . Patients with such mutations suffer from chronic granulomatous disease (CGD), characterized by severe recurrent infections. There are at least two other proteins thus far described to be involved in the NADPH oxidase: p40-phox, which was shown to reside in a complex with p67-phox in the cytosol of resting neutrophils (6, 7) , and the small GTPase p21-racl or p21-rac2 (8, 9) . This latter protein, unlike p40-phox, is essential for the activity of the NADPH oxidase (10, 11) .
The most common form of CGD ('--'60% of cases) is X linked and caused by mutations in the CYBB gene encoding the cytochrome b.sss [3 subunit (12) . Mutations in the CYBA gene encoding the tx subunit of the cytochrome lead to a rare, autosomal form of the disease, found in "~ of patients (13) . The 47-kD component is encoded by the NCFI gene; mutations in this gene lead to the common autosomal-recessive type of CGD, with an estimated incidence of 30% (14, 15) . Finally, another rare autosomal type of CGD is caused by mutations in the NCF2 gene, encoding p67-phox (16) . This type of CGD is called A67 CGD and is found in <5% of patients. So far, all reported A67 CGD patients completely lack material immunoreactive with antibodies directed against p67-phox. Only three of these patients have been characterized at the molecular level (17) (18) (19) . All three patients appeared to be homozygous for a mutation in the NCF2 gene. We here report on two hetereozygous mutations in an additional p67-phoxaffected CGD patient. Interestingly, one of these mutations apparently leads to the expression of a nonfunctional p67-phox protein. Since p67-phox has been shown to interact with p21-rac1 (20) , we investigated the effect of this mutation on this interaction and found it to be impaired.
Clinical History
A girl, born in 1976 in Chile to parents of South American origin, was adopted by Swedish parents in 1977. A medical examination at arrival in Sweden revealed only a calcified lymph gland in the left axillae. At age 2, she had a left-sided lobar pneumonia. In 1980, an abscess in her parotid gland revealed growth of Pseudomonas cepacia. At age 7, she had an abscess in her left axillae, but cultures were negative. Histologic examination showed unspecific necrotizing inflammation without granuloma formation. The same year she developed sterile pyuria. At age 9, she developed synovitis at the distal tibial bone. The possibility of tuberculosis was considered; however, tuberculosis cultures as well as regular cultures were negative. A biospy from the tibial bone revealed osteitis but no granuloma. The same year, granulocyte function tests showed no increase in oxidative metabolism. Thus, the diagnosis of CGD was established. She was treated with rifampicin and trimethoprimsulphamethoxazole for her osteitis and was thereafter put on prophylactic treatment with trimethoprim-sulphamethoxazole. The symptoms in her joints disappeared gradually, and there are no sequalae visible on x-ray photographs. During the years 1986-1990 she suffered from repeated lymphadenitis and a swelling of the parotid gland, despite antibiotic prophylaxis. She was also treated for a Salmotwlla septicenfia. Since 1990, she has been well without antibiotic prophylaxis.
Materials and Methods
Purification of Granulocytes. Blood was drawn m venoject citrate tubes (Terumo Europe, Leuwen, Belgium), and gTauulocytes were purified as described previously (21) . The cells (>90% neutrophils and 2-10% eosinophils) were suspended in incubation medium (I32 mM NaC1, 6 mM KC1, 1.2 mM Na2HPO4, 1 mM CaC12, 1 mM MgC12, 20 mM Hepes, 5 mM glucose, and t).5% (wt/vol) human serum albumin (pH 7.4).
Fuftctional Tests. The nitro blue tetrazdmm (NBT) slide test was performed as described previously (22) . About 400 cells stained with nuclear fast red were examined and scored as formazan negative or positive.
NADPH oxidase activity was also measured in the cell-fi-ee activation system as previously described (23) . In short, purified plasma membranes from sonicated granulocytes (I0 I~g of protein) and cytosol from sonicated granulocytes (120 I.tg of protein) were incubated at 28~ in 800 I-tl ofoxidase buffer (pH 7.2) containing 75 mM NaCI, 20 mM Hepes, 170 mM sucrose, 1 mM MgC12, (i).5 mM EGTA, and 60 ~M ferricytochrome c. The assembly of oxidase components was started by the addition of SI)S (100 I~M). NADPH (250 IxM) was added after 3 nfin, and NADPH oxidase activity was measured by the slope of the absorbance change at 550 nm.
H/estern Blotting. The presence of NADPH oxidase colnponents was determined on Western blots with antisera specific tbr the cytosolic components as described (23) .
Preparation of RNA and DNA. P, NA was isolated from mononuclear leukocytes as described previously (17) . Genomic DNA was isolated from circulating leukocytes (24) .
Northern Blottilg. P,.NA corresponding to 10 v monocytes (11) ~g) was submitted to electrophoresis in 1.2% (wt/voI) agarose gels in the presence of formaldehyde and was blotted onto Genescreen Plus membrane filters (NEN-l)upont, Boston, MA). Blots were hybridized with a p67-phox cl)NA probe containing the total coding region and labeled by random priming.
Southern Blotting. Analysis ofgenonfic 1)NA by Southern blot was performed after treatment with EcoRI or HindlIl essentially as described (25) . For hybridization, a full-length p67-pbox cl)NA was used (17) .
Amplication and Sequencing qf DNA. For analysis ofmRNA sequences, first-strand cDNA was synthesized from t<NA. The p67-phox cDNA coding region was amplified by PCR in six overlapping fragments as described by (17) . The sequence of the oligonucleotide primers used for this PCR are also given reference 17. The PCIL product was purified with the Geneclean I1 kit (BIO 1(/1, Inc., Vista, CA) to remove the primers and nucleotides. 20/) ng of the purified I)NA samples was annealed with 40 ng of one of the printers used for amplification by first being heated tbr 3 min at 100~ and then being chilled on ice water in the presence of 10% DMSO. Direct sequence analysis was performed with the sequenase version 2.0 kit (United States Biochemical Corp., Cleveland, OH). In genomic I)NA, the mutations were identified in a similar way.
Analysis of p21-racl Bindi,g to Ghctatllione-S-Tr,m.!'fi!rase (GS'I) Fusion ProteiHs.
To introduce the deletion of amino acid 58 in p67-phox we used a wild-type p67-pllox construct in pGEX-2T (Pharmacia, Uppsala, Sweden) as a template in a PCR. with oligonucleotide primers 5'-CTGGTAAAGGCCTCTGCTTCAGTC-ATGTTCTTC-3' (sense) and 5'-GATGAATTCTAATCA-TGTCCCTGGTGG-3' (antisense). The product was digested with Stul and EcoRl (underlined nucleotides) and ligated into the Stul/Ecol-ZI-digested pGEX-p67tvt plasmid. The introduced deletion was confirmed by sequencing. Expression of GST fusion Figure 1 . lmmunoblot analysis. Blood was drawn from healthy donors and patients after informed consent had been obtained, and granulocytes were purified and fractionated as described previously (28, 32) . Granulocyte cytosol (20 ptg of protein) from either healthy donors (con I and con2), from the patient (A67) or from a classical p67-phox-deficient patient (A67 ~ were separated on a 10% polyacrylanfide gel and subsequently blotted onto nitrocellulose. Staining with polyclonal antibodies against the COOH-terminal regions of these proteins revealed a diminished amount of p67-phox in the patient's granulocytes.
proteins was performed in Escherichia coli DH5(x as previously described (26) . Protein expression was compared by gel electrophoresis and protein staining. We found that the mutated p67-phox was poorly expressed; ~10-fold less than wild-type p67-ph0x. GST alone, GST-p47-phox, GST-p67-phox, or GST-p67-phoxASULys were spotted onto nitrocellulose. The blot was then incubated with [32p]~xGTP-loaded p21-rac1 as described (27) . Binding was visualized by subsequent exposure of the blot to hyperfihn-ECL (Amersham Corp., Arlington Heights, IL) for t h.
Tra,slocation of p47-phox and p67-phox in Intact Granulocytes.
Cells were stinmlated with PMA (100 ng/ml) or serum-treated zymosan (STZ; 1 mg/ml) for 7 rain and fractionated as described (24) . Subsequently, supernatants and plasma membranes were immunoblotted as described (28) .
TratMocation of p47-phox and p67-phox in the Cell-free System. 1 txg GST-p47-phox, 1 txg GST-p67-phox, and a fraction containing p21-rac (obtained from 240 txg ofcytosolic protein) (29) were mixed with plasma membranes (40 txg). After activation with SDS and GTP'yS and centrifugation over sucrose gradients, plasma membranes were collected as described (24) . One-fifth of the membrane fractions was assayed for superoxide production, and the remainder was TCA precipitated and processed for Western blotting.
Results and Discussion
Identification of CGD Type. The patient was identified as a C G D patient by lack o f superoxide generation by her purified granulocytes after activation with PMA in the N B T slide test. Likewise, her cells did not show any superoxide dismutase (SOD)-sensitive cytochrome c reduction with several other stimuli tested (fMLP, STZ, platelet-activating factor [PAF]), indicating a total lack o f N A D P H oxidase activity. In the cell-free activation system, the cytosol of the patient's granulocytes showed only 3% of normal activity, whereas the membranes o f these cells had normal activity. The cytosolic activity of the patient's cells was fully restored by addition of recombinant p67-phox protein, but not by addition of recombinant p47-phox. O n Western blots, p47-phox was clearly present in the cytosol of the patient's resting granulocytes, but p67-phox was also detected, albeit at a lower level (Fig. 1) . Densitometric scanning of 1245 Leusen et al.
the blots showed 46 + 9% (mean + SD, n = 3) of the normal amount ofp67-phox. Thus, the patient suffers from the autosomal form of C G D leading to subnormal amounts of p67-phox, also called the A67 + C G D subtype.
Identification of the Mutations O n Northern blot, the size and the amount ofp67-phox m R N A of the patient was apparently normal (not shown). The p67-phox mP, N A of the patient was converted to c D N A and amplified in six overlapping fragments. Electrophoresis on agarose gel showed that the amplified fragments from the patient had a size similar to that of fragments obtained from normal control cells. Direct sequencing of the first fragment with primer 67-109 (17) revealed a triplet nucleotide deletion between position 170 and 174, predicting deletion of a lysine at amino acid position 58. This mutation appeared to be confined to one allele, because the normal sequence was also detectable, albeit faintly. Therefore, we amplified genomic D N A from the patient with primer 67-27 (on exon 2) and primer 67-28 (on intron 2) and directly sequenced this fragment with primer 67-30 (also on intron 2; see reference 17). Again, the AGA 170-172 or GAA 171-173 or AAG 172-174 deletion was found, this time with the normal sequence at equal intensity (data not shown; a schematic representation is given in Fig. 2 A) . Analysis of the other amplified c D N A fragments from this patient revealed no other mutations. However, Southern blot analysis of nonamplifled genomic D N A with a full-length p67-phox c D N A probe after treatment with restriction enzyme E c o R I showed a much weaker stained 5-kb band than in the control situation (Fig. 2 C) . In addition, after treatment with HindlII, an abnormal extra band of ~1 3 kb was found (Fig. 2 /3 ). These results are compatibile with an 11-13-kb deletion in the N C F -2 gene. Thus, the patient seems to be a compound heterozygote for a 5SLys deletion and a larger deletion in p67-phox. Family members of this patient were not available for study.
Translocation of p47-phox and p67-phox in Intact Granulocytes. Apparently, the p67-phox with the predicted inframe deletion of SSLys was expressed in the patient's cells, because a band of normal size was detected on Western blot (Fig. 1) . The lower expression o f the protein is abnormal: carriers of A67 ~ have (almost) normal amounts ofp67-phox protein in their neutrophil cytosol (unpublished results). The product from the patient's other allele with the large deletion was not expressed, because no protein of lower size was detected. To analyze the functional defect in this patient, we studied the translocation of p67-phox and p47-phox in the granulocytes activated with PMA or STZ.
As shown in Fig. 3 , PMA in normal cells induced a fair translocation of both p47-phox and p67-phox, and STZ (a more physiological stimulus) induced a mitigated translocation, probably caused by a less stable assembly of N A D P H oxidase. However, in the patient's cells, both proteins failed to translocate to the plasma membrane and were retained in the supernatant with both stimuli. In granulocytes ofp67-phox-deficient patients, it has been found that p47-phox can translocate on its own (30, 31) . Nevertheless, we found < 1% interaction ofp47-phox with the plasma mem- brane of another p67-phox-deficient patient, both in P M Aactivated granulocytes and in the cell-free system (J. Leusen, unpublished results). Also, in C G D patients with a n m t ation in either the light or the heavy subunit of cytochrome bss ~, we found virtually no translocation of either p47-phox or p67-phox (28, 32) .
Translocation of p47-phox and p67-phox in the Cell-free System. In the patient described here, the lack of translocation of both cytosolic phox proteins could be the consequence of a disturbed b i n d i n g of the mutated p67-phox to cytochrome bss 8. T o investigate this possibility, we tested the translocation o f n m t a t e d p67-phox as a fusion protein to G S T in the cell-free sytem. As shown in Fig. 4 , p47-phox and p67-phox translocate to the plasma membrane, using either wild-type or mutated p67-phox. The cytes. Cells were stimulated with PMA (100 ng/ml) or STZ (1 mg/ml) for 7 rain and fractionated. Subsequently, supernatants and plasma membranes were immunoblotted as described in Fig. 1 . small GTPase p21-rac1 can specifically interact with p67-phox (20, 27) , the first 199 a m i n o acids ofp67-phox being important for this interaction. As s h o w n in p67-phox (data not shown). These results suggest that 5SLys ofp67-phox is in a putative b i n d i n g site for p21-racl, or, alternatively, is important for maintaining the N H 2 terminus in a proper conformation for p21-rac1 binding.
For the past two years, conflicting data have been p u blished about the function o f p21-rac proteins in the assembly o f N A D P H oxidase. It has been unclear whether or not p21-rac becomes stably associated with the plasma m e r ebrane u p o n cell activation (33) (34) (35) , and whether translocation of p21-rac is dependent or i n d e p e n d e n t o f p47-phox and p67-phox (36) (37) (38) (39) (40) . T h e only aberration we observed in the neutrophils o f this C G D patient was the inability of its mutant p67-phox protein to interact with p21-rac1, whereas interaction with p21-rac2 (as reported by Dorseuil et al. [41] ) could not be demonstrated even with the wild-type p67-phox. O u r results seem therefore to corroborate the results of Dusi et al. (42) , w h o reported that the translocation ofp21-racl, but n o t that ofp21-rac2, is dependent on the presence o f p47-phox and p67-phox. T h e interaction b e t w e e n p21-racl and p67-phox may not only be m a n d atory for proper N A D P H oxidase assembly (as indicated by the disturbed translocation of cytosolic c o m p o n e n t s in the neutrophils o f this patient), but also for induction of catalytic activity: the mutated p67-phox translocated in the cellfree system (i.e., under artificial conditions) did n o t support oxidase activity. Binding was visualized by subsequent exposure of the blot to film for 1 h. Afterward, the presence of p67-phox was verified by immunostaining with an antibody against the COOH temainus of p67-phox visualized by enhanced chemiluminescence (right).
